Prothena | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
ALKERMES USD 443.75M 333.52M 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Exelixis USD 184.77M 30.02M 2024-12
Incyte USD 406.83M 147.12M 2024-12
Intra Cellular Therapies USD -17202000 8.75M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
MacroGenics USD 56.31M 111.97M 2024-09
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Prothena USD -59501000 335K 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Prothena Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.